Shorter telomere length in carriers of APOE-ε4 and high plasma concentration of glucose, glyoxal and other advanced glycation end products (AGEs).
Apolipoprotein-ε4 (APOE-ε4) - common variant is a major genetic risk factor for cognitive decline and Alzheimer's disease (AD). An accelerated rate of biological aging could contribute to this increased risk. Glycation of serum proteins due to excessive glucose and reactive oxygen species leads to the formation of advanced glycation end products (AGEs) - a risk factor for diabetes and AD, and decline in motor functioning in elderly. Aim of present study was to investigate impact of APOE-ε4 allele containing genotype and accumulation of AGEs in plasma on telomere length (TL). Results showed that TL is significantly shorter in APOE-ε4 carriers compared to non-APOE-ε4 carriers (p = 0.0003). Higher plasma glucose level was associated with shorter TL irrespective of APOE-ε4 allele containing genotype (r = - 0.26; p = 0.0004). With regard to AGEs, higher plasma glyoxal and fluorescent AGEs concentrations were inversely related to TL (r = - 0.16; p = 0.03; r = - 0.28; p = 0001), however, plasma Nε-(carboxymethyl)lysine levels didn't correlate with TL (r = - 0.04; p = 0.57). Results support the hypotheses that APOE-ε4 carriers have shorter telomeres than non-carriers and telomere erosion is increased with higher concentration of glucose, fluorescent AGEs and glyoxal.